Stereotactic body radiotherapy with or without external beam radiation as treatment for organ confined high-risk prostate carcinoma: a six year study

Stereotactic Body Radiotherapy (SBRT) has excellent control rates for low- and intermediate-risk prostate carcinoma. The role of SBRT for high-risk disease remains less studied. This paper, published in Radiation Oncology, presents long-term results on a cohort of patients with high-risk disease treated with SBRT.

7th Space